Pegloticase
Horizon Therapeutics
['methotrexate']
#plenary session. dr. botson presents with mirror rct db pbo randomized trial looking at #pegloticase with and wo #methotrexate. 71% combo mtx met primary end point vs 38% pbo. secondary end point - tophus resolution. 20-22% improvement over pbo. #gout #acr22 
Rheumatologist | @ACRheum MarCom Chair | @TexMed Delegate | TexMed Leadership College????? | ???? | Views = Mine | Re-tweet ? endorsement